And so it begins 👀 globenewswire.com/news-release/2…

Wednesday (3/17), 5 p.m. ET: At the one-year mark of the pandemic, join The Atlantic science writers @yayitsrob, Ed Yong is not here and Sarah Zhang, as well as senior editor Sarah Laskow, for a discussion of the "pandemic beat." Register: bit.ly/2Q3189L

Types of Scientific Paper xkcd.com/2456/ m.xkcd.com/2456/

UC Berkeley is auctioning NFT's of famous "invention disclosure forms" (that's when a prof tells the university about a patentable idea, sealing the invention date). First to auction is Jim Allison's idea for immunotherapy blockade Later they'll do Jennifer Doudna's CRISPR. 1/

The complete sequence of a human genome biorxiv.org/content/10.110…

If Darwin went on his voyage of the Beagle today his research would've ended with a t-SNE of the bird specimens that he collected instead of a theory of evolution

Illumina, BGI settle multi-front legal battle in the US genomeweb.com/sequencing/ill… Illumina BGI Group #NGS

Illumina launches new NovaSeq X series. At most powerful: 16 terabytes output at $2 per Gb #NGS

Illumina Strikes Back: New NovaSeq X Series Sequencers to Push Boundaries on Throughput, Cost genomeweb.com/sequencing/ill…

Non-Profit's Efforts With Payors to Assess NGS Labs' Variant Interpretations Spark Debate. If the Center for Genomic Interpretation's in silico quality assessment catches on with payors, some labs are sure to push back or propose data sharing as an... ow.ly/QXrn1044Zee

US Department of Defense Adds BGI Genomics to Blacklist of 'Chinese Military Companies' genomeweb.com/sequencing/us-…

what are the best examples of GWAS that have led to clinical interventions (and not polygenic scores) - i mean something like GWAS --> gene --> genomic characterization of gene --> diagnostic or therapy

Michael 英泉 Eisen ANGPTL3 was first connected to LDL cholesterol levels by GWAS, ultimately leading to an approved treatment for homozygous familial hypercholesterolemia (evinacumab) and other treatments in development.

Michael 英泉 Eisen nextgenseek TYK2 is the sitter. Not sure if you count PCSK9 or not. Both rare and common disease highly predictive (odds ratio) for success in phase II (right disease trial) and in many pharma now working into assessment for Phase II trials (have you chosen the right disease) >>

New long-read sequencer from PacBio announced at #ASHG genomeweb.com/sequencing/pac…

PacBio presentation slide at #ASHG22 yesterday mentioned both the "Onso sequencing platform" and "Onso cluster generator." Does that mean what I think it means?

A few of us from the Single Cell Genomics team went to a stained glass workshop Color Glass Shop. I asked the friendly sequencing lab techs in the CNAG to save the used Illumina flow cells, and here is my first attempt at sci-art 🧪🎨. It could be a flower, or the sun, or...?

First draft is ready on Arxiv. Many thanks to Martijn van den Ende Sylvain Barbot and Dr. Susan Hough and others. I will try to submit it soon. arxiv.org/abs/2303.11802

Hello, new and old friends - I'm happy to announce I've joined the incredible team at DIMENSION (DIMENSION) as the firm's Research Director, where I'll help shape our research practice. I'll be active on Twitter and SubStack: simonbarnett.substack.com